文献速递主动脉外科

急性A型主动脉夹层合并肠系膜灌注不良综合征的处理:20年经验

Managing patients with acute type A aortic dissection and mesenteric malperfusion syndrome: A 20-year experience.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-12-14

本研究回顾了1996至2017年间602例急性A型主动脉夹层患者,其中82例(14%)合并肠系膜灌注不良综合征(mesMPS),均先行血管内开窗/支架置入再延迟开放主动脉修复。mesMPS患者院内死亡率为39%,但恢复后行开放修复者手术死亡率与无灌注不良综合征患者无显著差异。

要点

  • mesMPS患者先血管内再灌注再延迟开放修复,可获较好近远期结果。
  • 急性卒中、剖腹探查见肠坏死、乳酸≥6 mmol/L是再灌注后器官衰竭死亡风险因素。
  • 恢复后开放修复的手术死亡率与无灌注不良综合征者无显著差异。

核心结论

  • 对急性A型主动脉夹层合并mesMPS患者,先血管内开窗/支架置入再延迟开放主动脉修复可获得良好的短期和长期结果。
  • 外科医生应考虑在开放主动脉修复前纠正肠系膜灌注不良,尤其对急性卒中、剖腹探查见肠坏死或血清乳酸≥6 mmol/L者。

研究设计与样本

  • 回顾性队列研究,纳入1996至2017年单中心602例急性A型主动脉夹层患者,其中82例(14%)合并mesMPS均先行血管内开窗/支架置入,419例无任何器官灌注不良综合征者为对照。
  • 主要结局为院内死亡率和长期生存。

主要发现

  • mesMPS患者院内死亡率为39%。
  • 血管内开窗/支架置入后,20例(24%)死于器官衰竭,11例(13%)在开放主动脉修复前死于主动脉破裂,47例(58%)接受主动脉修复,4例(5%)未行开放修复存活。
  • 第二个十年(2008-2017)无患者死于主动脉破裂。
  • 再灌注后死于器官衰竭的显著风险因素包括急性卒中(OR 23,95%CI 4-144,P=.0008)、剖腹探查见肠坏死(OR 7,95%CI 1.4-34,P=.016)和血清乳酸≥6 mmol/L(OR 13.5,95%CI 2-97,P=.0097)。
  • mesMPS恢复后行开放主动脉修复者与无灌注不良综合征者相比,手术死亡率(2.1% vs 7.5%,P=.50)和长期生存无显著差异。

关键数值与推荐

  • mesMPS患者院内死亡率为39%。
  • 再灌注后器官衰竭死亡风险因素:急性卒中OR 23(95%CI 4-144,P=.0008);剖腹探查见肠坏死OR 7(95%CI 1.4-34,P=.016);血清乳酸≥6 mmol/L OR 13.5(95%CI 2-97,P=.0097)。
  • mesMPS恢复后开放修复者与无灌注不良综合征者手术死亡率2.1% vs 7.5%(P=.50)。

临床怎么用

  • 对急性A型主动脉夹层合并mesMPS的稳定患者,可先行血管内开窗/支架置入再灌注,再延迟开放主动脉修复。
  • 对合并急性卒中、剖腹探查见肠坏死或血清乳酸≥6 mmol/L者,应优先纠正肠系膜灌注不良后再考虑开放主动脉修复。

局限性

  • 单中心回顾性研究,样本来自1996至2017年,可能存在选择偏倚。
  • mesMPS组样本量较小(82例),部分亚组分析效能有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess outcomes of endovascular reperfusion followed by delayed open aortic repair for stable patients with acute type A aortic dissection and mesenteric malperfusion syndrome (mesMPS). METHODS: Among 602 patients with acute type A aortic dissection who presented to our center from 1996 to 2017, all 82 (14%) with mesMPS underwent upfront endovascular fenestration/stenting. Primary outcomes were in-hospital mortality and long-term survival. Patients with acute type A aortic dissection with no malperfusion syndrome of any organ (n = 419) served as controls. RESULTS: In-hospital mortality of all comers with mesMPS was 39%. After endovascular fenestration/stenting, 20 mesMPS patients (24%) died from organ failure and 11 patients (13%) died from aortic rupture before open aortic repair, 47 patients (58%) underwent aortic repair, and 4 patients (5%) survived without open repair. No patients died from aortic rupture during the second decade (2008-2017). The significant risk factors for death from organ failure after endovascular reperfusion were acute stroke (odds ratio, 23; 95% confidence interval, 4-144; P = .0008), gross bowel necrosis at laparotomy (odds ratio, 7; 95% confidence interval, 1.4-34; P = .016), and serum lactate ≥6 mmol/L (odds ratio, 13.5; 95% confidence interval, 2-97; P = .0097). There was no significant difference in operative mortality (2.1% vs 7.5%; P = .50) or long-term survival between patients with mesMPS who underwent open aortic repair after recovering from mesMPS and patients with no malperfusion syndrome. CONCLUSIONS: In patients with acute type A aortic dissection with mesMPS, endovascular fenestration/stenting, and delayed open aortic repair achieved favorable short- and long-term outcomes. Surgeons should consider correcting mesenteric malperfusion before undertaking open aortic repair in patients with mesMPS, especially those with acute stroke, gross bowel necrosis at laparotomy, or serum lactate ≥6 mmol/L.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Yang B, Norton EL, Rosati CM, et al. Managing patients with acute type A aortic dissection and mesenteric malperfusion syndrome: A 20-year experience. J Thorac Cardiovasc Surg. 2018. PMID: 30711274. doi:10.1016/j.jtcvs.2018.11.127

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。